tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate

We are tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate CAS:3319-31-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms:
tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate
Kodaflex TOTM
triethylhexyl trimellitate
Tris(2-ethylhexyl) Trimellitate
Hatcol 200
Trioctyl benzene-1,2,4-tricarboxylate
Trioctyl Trimellitate
Trimellitic Acid Tris(2-ethylhexyl) Ester
Monosizer W710L
Morflex 510
2-ethylhexyl trimellitate
Staflex TOTM
Tris(2-ethylhexyl)trimellitate
TOTM (Tris(2-ethylhexyl) trimellitate
Trioctyl 1,2,4-Benzenetricarboxylate
1,2,4-Benzenetricarboxylic Acid Tris(2-ethylhexyl) Ester
Totm
tri-2-ethyl hexyl trimellitate
 
Molecular Formula: C33H54O6
Molecular Weight: 546.77800

Appearance and properties: colorless or light yellow transparent oily liquid
Density: 0.990 g/mL at 20 °C(lit.)
Boiling point: 414 °C(lit.)
Melting point: 46ºC
Flash point: 505 °F
Refractive index: n20/D 1.485(lit.)
 
Stability: Stable. Combustible. Incompatible with strong oxidizing agents.
Storage conditions: Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Applications: used as a plasticizer for PVC products and heat-resistant cables
Items of Analysis Standard of Analysis Test Results
Appearance  Transparent, no visible impurities, oily liquid Conform
Ester content ≥99.50% 99.85%
Acid value ≤0.10% 0.060%
Moisture ≤0.05% 0.013%
Color ≤50 Pt-Co 20 Pt-Co
Volume resistivity(20℃) ≥6.0×1011 16.58×1011
Flash point ≥245℃ 256℃
Density (20℃) 0.984-0.991 g/cm3 0.989 g/cm3
Heating loss(125℃×3hrs) ≤0.1% 0.04%
DOP/DEPH ≤500 ppm N/A
2-Ethyl hexanol ≤1000 ppm N/A
Antioxidant content ≤3000 ppm 1500
Index of Refraction(nD20) 1.482-1.488 1.485
Conclusion Conforms to Factory Standard


tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate


Related News: “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.1-(4-methylbenzyl)piperazine dihydrochloride “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.α-D-Glcp-(1-)2)-D-Glcp The latest outbreak comes as China grapples with an African swine fever epidemic that has infected tens of thousands of pigs. It could stoke more worries among its people about the country’s food supply.Silane, trimethyl(tricosyloxy)- According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.The Philippines reported its first Wuhan coronavirus fatality on Sunday.

Related Products
Product Name
Collagen View Details
sodium,2-chloro-2,2-difluoroacetate View Details
Difurfurylsulfide View Details
2,2-Diethoxyacetophenone manufacturer Z-ALA-ALA-OME manufacturer Palladium catalyst compounds manufacturer N-[3-[5-bromo-1-(2,6-dichlorobenzoyl)pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide manufacturer Potassium Sulfate manufacturer